EMC Instytut Medyczny SA (EMC.WA)
PLN 10.6
(2.91%)
PLN 10.6
(2.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 58.71 Million PLN | 202.78% |
| 2022 | 25.73 Million PLN | -43.96% |
| 2021 | 34.83 Million PLN | 67.67% |
| 2020 | 21.45 Million PLN | -7.23% |
| 2019 | 21.35 Million PLN | 165.79% |
| 2018 | 5.88 Million PLN | -70.42% |
| 2017 | 19.39 Million PLN | 259.08% |
| 2016 | -3.7 Million PLN | -22.38% |
| 2015 | 11.57 Million PLN | 27.99% |
| 2014 | 7.61 Million PLN | -38.67% |
| 2013 | 13.41 Million PLN | 6.74% |
| 2012 | 11.41 Million PLN | 0.63% |
| 2011 | 11.84 Million PLN | 91.55% |
| 2010 | 8.88 Million PLN | -50.11% |
| 2009 | 11.42 Million PLN | 15.85% |
| 2008 | 10.07 Million PLN | 109.99% |
| 2007 | 4.87 Million PLN | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 13.33 Million PLN | -6.46% |
| 2024 Q2 | 10.67 Million PLN | -21.1% |
| 2023 Q2 | 16.29 Million PLN | 32.15% |
| 2023 Q3 | 18.71 Million PLN | 14.88% |
| 2023 FY | - PLN | 202.78% |
| 2023 Q4 | 14.05 Million PLN | -24.93% |
| 2023 Q1 | 12.33 Million PLN | 167.75% |
| 2022 Q4 | 4.6 Million PLN | -63.72% |
| 2022 Q3 | 12.69 Million PLN | 51.54% |
| 2022 Q2 | 8.37 Million PLN | 123.0% |
| 2022 Q1 | 3.75 Million PLN | -72.06% |
| 2022 FY | - PLN | -43.96% |
| 2021 Q3 | 8.37 Million PLN | 24.63% |
| 2021 Q1 | 6.57 Million PLN | 161.2% |
| 2021 Q2 | 6.71 Million PLN | 2.11% |
| 2021 FY | - PLN | 67.67% |
| 2021 Q4 | 13.44 Million PLN | 60.63% |
| 2020 Q1 | 5.26 Million PLN | -25.72% |
| 2020 Q3 | 6.13 Million PLN | -14.72% |
| 2020 Q4 | 2.51 Million PLN | -58.97% |
| 2020 FY | - PLN | -7.23% |
| 2020 Q2 | 7.19 Million PLN | 36.81% |
| 2019 Q2 | 4.21 Million PLN | 25.12% |
| 2019 Q3 | 6.06 Million PLN | 43.81% |
| 2019 Q4 | 7.08 Million PLN | 16.85% |
| 2019 FY | - PLN | 165.79% |
| 2019 Q1 | 3.36 Million PLN | 357.3% |
| 2018 Q4 | -1.3 Million PLN | -162.75% |
| 2018 FY | - PLN | -70.42% |
| 2018 Q1 | 2.14 Million PLN | -79.16% |
| 2018 Q2 | 2.44 Million PLN | 13.7% |
| 2018 Q3 | 2.08 Million PLN | -14.51% |
| 2017 Q1 | 3.71 Million PLN | 9873.68% |
| 2017 Q4 | 10.29 Million PLN | 342.92% |
| 2017 FY | - PLN | 259.08% |
| 2017 Q3 | 2.32 Million PLN | -19.1% |
| 2017 Q2 | 2.87 Million PLN | -22.62% |
| 2016 FY | - PLN | -22.38% |
| 2016 Q4 | -38 Thousand PLN | -101.72% |
| 2016 Q2 | 1.99 Million PLN | -36.01% |
| 2016 Q3 | 2.21 Million PLN | 11.19% |
| 2016 Q1 | 3.11 Million PLN | 176.71% |
| 2015 Q3 | 1.87 Million PLN | -45.55% |
| 2015 Q4 | 1.12 Million PLN | -40.1% |
| 2015 FY | - PLN | 27.99% |
| 2015 Q1 | 4.6 Million PLN | 291.16% |
| 2015 Q2 | 3.44 Million PLN | -25.1% |
| 2014 Q3 | 1.9 Million PLN | -49.0% |
| 2014 Q4 | -2.4 Million PLN | -226.19% |
| 2014 Q1 | 4.37 Million PLN | 149.66% |
| 2014 Q2 | 3.74 Million PLN | -14.43% |
| 2014 FY | - PLN | -38.67% |
| 2013 Q1 | 4.57 Million PLN | 869.28% |
| 2013 Q4 | 1.75 Million PLN | -50.01% |
| 2013 Q3 | 3.5 Million PLN | 24.78% |
| 2013 Q2 | 2.8 Million PLN | -38.6% |
| 2013 FY | - PLN | 6.74% |
| 2012 Q1 | 4.73 Million PLN | 64.78% |
| 2012 Q4 | 472 Thousand PLN | -85.79% |
| 2012 Q3 | 3.32 Million PLN | -1.22% |
| 2012 Q2 | 3.36 Million PLN | -28.96% |
| 2012 FY | - PLN | 0.63% |
| 2011 Q2 | 3.95 Million PLN | 6002.99% |
| 2011 FY | - PLN | 91.55% |
| 2011 Q4 | 2.87 Million PLN | -43.31% |
| 2011 Q3 | 5.06 Million PLN | 28.14% |
| 2011 Q1 | -67 Thousand PLN | 93.9% |
| 2010 Q4 | -1.09 Million PLN | -145.1% |
| 2010 FY | - PLN | -50.11% |
| 2010 Q2 | 1.9 Million PLN | -84.19% |
| 2010 Q1 | 12.06 Million PLN | 408.55% |
| 2010 Q3 | 2.43 Million PLN | 27.73% |
| 2009 Q3 | 2.83 Million PLN | -32.68% |
| 2009 Q4 | 2.37 Million PLN | -16.41% |
| 2009 FY | - PLN | 15.85% |
| 2009 Q1 | 10.69 Million PLN | 0.0% |
| 2009 Q2 | 4.21 Million PLN | -60.57% |
| 2008 FY | - PLN | 109.99% |
| 2007 FY | - PLN | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Centrum Medyczne ENEL-MED S.A. | 91.1 Million PLN | 35.552% |